Seres Therapeutics, Inc.

NASDAQ:MCRB

Biotechnology

Healthcare
$5.28 +1.70%

+$0.11 today

Market cap
$51.13M
Beta
0.11
P/E (TTM)
-1.3
EPS (TTM)
-$4.89
52W Low $5.31High $29.98

Volume 0.04M

Average 0.06M

Balance Sheet

Inspect the capital base behind the business.

Assets

$138.19M

FY 2025 · Annual

-1.2% YoY

Liabilities

$93.97M

FY 2025 · Annual

-25.4% YoY

Equity

$44.22M

FY 2025 · Annual

+220.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents180M163.03M127.97M30.79M45.77M
Short-term Investments110.7M18.31M000
Net Receivables0004.75M360K
Inventory0029.65M00
Other Current Assets013.42M17.8M3.13M3.25M
Total Current Assets303.63M194.76M175.41M38.67M49.38M
Property, Plant & Equipment (Net)36.15M133.97M108.03M92.44M80.12M
Goodwill00000
Intangible Assets00000
Long-term Investments495K9.59M9.59M8.67M8.67M
Tax Assets00000
Other Non-current Assets14.59M10.47M65.57M31K31K
Total Non-current Assets51.23M154.02M183.19M101.14M88.82M
Total Assets354.86M348.78M358.6M139.81M138.19M
Account Payables13.74M17.44M3.64M4.08M1.68M
Short-term Debt0456K0010.39M
Tax Payables00000
Deferred Revenue16.82M4.26M7.73M00
Other Current Liabilities21.1M34.77M59.19M17.75M4.57M
Total Current Liabilities82.26M85.6M98.66M41.22M19.32M
Long-term Debt24.64M50.59M101.54M00
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)87M92.43M95.36M00
Other Non-current Liabilities11.5M1.44M16.24M1.84M2.08M
Total Non-current Liabilities141.09M252.41M304.8M84.8M74.65M
Total Liabilities223.35M338M403.46M126.03M93.98M
Common Stock92K125K135K173K10K
Retained Earnings(614.35M)(864.51M)(978.24M)(978.1M)(972.4M)
Accumulated OCI(60K)(12K)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity131.51M10.78M(44.86M)13.78M44.22M
Total Debt49.21M162.59M198.78M91.64M82.97M
Net Debt(130.79M)(440K)70.82M60.85M37.2M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$29.8M
Receivables$233.0K
Other Current$1.8M
Total Current Assets$31.8M
PP&E (Net)$77.1M
Long-term Investments$8.7M
Other Non-current$31.0K
Total Non-current Assets$85.8M
Total Assets$117.6M

Analysis

Selected assets total $117.6M for Latest. The largest visible component is PP&E (Net) at $77.1M, about 65.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
EFFECTEFFECT filingAug 21, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
4Statement of changes in beneficial ownershipAug 18, 2026

How much cash does MCRB have?

Seres Therapeutics, Inc. (MCRB) reported $45.77M in cash and equivalents in fiscal 2025.

How much debt does MCRB carry?

Seres Therapeutics, Inc. (MCRB) reported $82.97M of total debt, with net debt of $37.20M.